News and Events

ChemBridge to Attend EFMC-ISMC International Symposium on Medicinal Chemistry, Sept. 2 - 6, Ljubljana, Slovenia

San Diego, CA, USA, July 2, 2018

The EFMC-ISMC International Symposium on Medicinal Chemistry will be held in Ljubljana, Slovenia, September 2-6, 2018. The XXV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2018) is organised by the Section for Medicinal Chemistry of the Slovenian Pharmaceutical Society (SFD), on behalf of the European Federation for Medicinal Chemistry (EFMC).

The 2018 edition will cover drug discovery advances in major therapeutic areas, including the treatment of inflammatory and autoimmune diseases, infectious diseases including fungal infections, cardiometabolic diseases, neurodegenerative diseases, and oncology.

EFMC-ISMC 2018 will present the most recent advances in up-to-date topics like protein degradation, STING pathway, kinetics and pharmacokinetics of drug binding and PET imaging, and will tackle some out-of-the-box areas of Medicinal Chemistry including carbohydrate-based vaccines and new chemical modalities, while Chemical Biology approaches to target identification will cover the interfaces between chemistry, biology and experimental medicine. Particular emphasis will be put on first time disclosures, recent highlights in medicinal chemistry, and the impact of artificial intelligence in drug discovery.

ChemBridge will be attending and available to discuss our screening compound, macrocycle, and building block offerings for small molecule drug discovery and chemical biology research including:

  • Our stock of more than 1.3 million small molecule screening compounds including sp3-enriched screening compounds with more 3-dimensional structure
  • Our Macrocycle Library compounds and the Macrocycle CNS Subset
  • Diversity libraries including the DIVERSet-CL and DIVERSet-EXP Libraries
  • Targeted libraries and biased screening libraries for kinase, ion channel, GPCR, nuclear receptor and CNS research
  • Fragment Library compounds for fragment based drug discovery
  • Our stock of more than 14,000 building blocks / reagents for medicinal chemists

Please contact Dr. Reg Richardson, Business Development Europe, at to arrange a meeting.

back to top